[cmath] REMINDER: CIH Drug Development workshop May 2-3, 2022 (11AM - 2PM MDT)

[BIRS Facilitator]

This is a friendly reminder that the Career & Innovation Hub <https://careerandinnovationhub.ca/> “Mathematical Modelling Approaches to Virtual Clinical Trials <https://careerandinnovationhub.ca/mmavct2022/>” virtual workshop will take place May 2 - 3, 2022 from 11AM - 2PM (MDT - Calgary/Banff). The event is free to attend and is open to students at all levels. Visit the following webpage to register:

https://ubc.ca1.qualtrics.com/jfe/form/SV_cGV0M4mRBtdMRrD <https://ubc.ca1.qualtrics.com/jfe/form/SV_cGV0M4mRBtdMRrD>

This workshop will equip participants from mathematics and related disciplines with the tools necessary to solve common drug development questions in the pharmaceutical industry. The focus will be on development of pharmacometrics skills to approach questions centred on drug discovery and in silico (virtual) clinical trials using a variety of state-of-the-art model-informed drug development (MIDD), including quantitative systems pharmacology (QSP) methodologies. The workshop’s sessions will highlight modern modeling and simulation approaches applied to diverse pre- and post-clinical drug development questions, including methodological aspects of virtual clinical trial implementation, and the use of in silico clinical trials in immuno-oncology and other key drug development spaces. 

If you have any questions about the event please e-mail BIRS staff at birs-facilitator at birs.ca <mailto:birs-facilitator at birs.ca>. 

Best regards,

Jake Posacki
BIRS Station Facilitator
birs-facilitator at birs.ca <mailto:birs-facilitator at birs.ca>
________

Event webpage:
https://careerandinnovationhub.ca/mmavct2022/ <https://careerandinnovationhub.ca/mmavct2022/>

Registration page:
https://ubc.ca1.qualtrics.com/jfe/form/SV_cGV0M4mRBtdMRrD <https://ubc.ca1.qualtrics.com/jfe/form/SV_cGV0M4mRBtdMRrD>

More info on CIH:
https://careerandinnovationhub.ca/more-info/ <https://careerandinnovationhub.ca/more-info/>

-------------- next part --------------
Skipped content of type multipart/related